InphA GmbH, based in Bremen, is an institute for pharmaceutical and applied analytics that conducts examinations of medicinal products and medical devices within the scope of regulatory monitoring. The company also offers contract testing services for public institutions such as the federal government or the European Community, as well as for other third parties. The company employs an average of 26 staff members and is led by a full-time management team. The institute operates in both a non-commercial and a commercial sector. The company is a small company under § 267 (1) HGB and is therefore not required to publish a profit-and-loss statement.
Die Gesellschaft führt Untersuchungen von Arzneimitteln und Medizinprodukten, die im Rahmen der Überwachung im Zuständigkeitsbereich der Gesellschafter anfallen, sowie damit verbundene Tätigkeiten durch. Die Gesellschaft ist berechtigt, Auftragsuntersuchungen gegen kostendeckendes Entgelt für Einrichtungen anderer Länder, des Bundes oder der Europäischen Gemeinschaften durchzuführen, soweit die Erfüllung der Aufgaben nach Absatz 1 dadurch nicht beeinträchtigt wird. Die Gesellschaft ist darüber hinaus berechtig, entgeltlich Auftragsuntersuchungen gegenüber sonstigen Dritten durchzuführen, soweit die Erfüllung der Aufgaben nach Absatz 1 dadurch nicht beeinträchtigt wird.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Bremen Local Court, HRB 16583 (as of 20 November 2026)
| Name | Type | City |
|---|---|---|
| Elena Sacharow | Geschäftsführer(in) | Bremen |
Source: German Commercial Register (Handelsregister) Bremen Local Court, HRB 16583 (as of 20 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | small company1 | — | €2,254,528 | 25 |
| 2024 | €143,237 | -€2,284,414 | €1,905,566 | 26 |
| 2023 | €167,491 | -€2,125,690 | €2,009,025 | 25 |
| 2022 | €139,696 | -€2,043,608 | €1,927,644 | 24 |
| 2021 | €351,226 | -€1,992,077 | €2,217,763 | 25 |
| 2020 | small company1 | — | €2,432,783 | 26 |
| 2019 | small company1 | — | €2,649,705 | 25 |
| 2018 | small company1 | — | €2,452,803 | 23 |
| 2017 | €355,914 | -€1,506,771 | €2,430,814 | 23 |
| 2016 | €281,685 | -€1,466,333 | €2,484,812 | 24 |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Source: German Company Register (Unternehmensregister) · Annual accounts
Sign in to download data
Source: German Commercial Register (Handelsregister) Bremen Local Court, HRB 16583 (as of 20 November 2026)